Michelle Lamendola
Nurse Practitioner · Tempe, AZNPI 1760653836
Payments from drug & device makers
Across 157 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$758
- Merck$346
- AbbVie$129
- Pfizer$116
- Napo Pharmaceuticals Inc$99
- plus $619 from 16 others
What the payments were for
- Food & beverage$3,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 47 | $1,141 |
| Gilead | 47 | $758 |
| Merck | 15 | $346 |
| AbbVie | 6 | $129 |
| Pfizer | 6 | $116 |
| Napo Pharmaceuticals Inc | 6 | $99 |
| Johnson & Johnson | 3 | $75 |
| Amgen | 4 | $64 |
| Exact Sciences | 3 | $54 |
| Myriad Women's Health, Inc. | 1 | $53 |
| Lilly USA, LLC | 2 | $49 |
| Hologic Sales And Service, LLC | 2 | $49 |
| Novo Nordisk | 3 | $46 |
| AstraZeneca | 3 | $45 |
| EMD Serono, Inc. | 2 | $44 |
| Theratechnologies Inc. | 1 | $32 |
| Abbott | 1 | $23 |
| Phadia US Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Organon | 1 | $12 |
How this compares
$3,207 in reported general payments places this provider in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 46 | $183,586 |
| Gabapentin | 19 | $451 |
| Amlodipine Besylate | 12 | $132 |
| Lisinopril | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $758 | $183,58646 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Tempe
- Jennifer HeeterTempe$8K
- Ann MooreGlendale$2.1M
- Andrea KesslerLitchfield Park$780K
- Sandra KurtinTucson$201K
- Kristen HerzogScottsdale$162K
- Krista ArredondoChandler$133K
- Shannon MorgensternOro Valley$71K
- Helena In't VeldPhoenix$64K
- Steven KalfusChandler$43K
- Dustin NickersonPhoenix$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.